Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?

Immunotherapy. 2011 Mar;3(3):301-4. doi: 10.2217/imt.10.118.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Immunity, Innate
  • Immunotherapy / methods*
  • Models, Animal
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Toll-Like Receptor 9* / agonists
  • Toll-Like Receptor 9* / immunology

Substances

  • Antineoplastic Agents
  • Toll-Like Receptor 9